Buy 1P-LSD Tablets Online
1P-LSD 100 mcg is a substance sold for research purposes only and is not intended for consumption. 1P-LSD belongs to the category of lysergamides. Lysergamides have a potent effect on a number of dopamine receptors and serotonin receptors.
1P-LSD 100 mcg is supplied on blotters and remains stable for up to 2 years when stored in the correct environment. Because 1P-LSD is for research purposes only and not for consumption, it is important that the product is kept out of the reach of children and pets.
We offer good quality research chemicals at a reasonable price. Your order will be shipped every day within 24 hours. So order 1P-LSD safely and quickly via chemcloudnl.nl!
1P-LSD 100 mcg blotter properties
Synonyms: N,N-diethyl-7-methyl-4-propanoyl-6,6a,8,9-tetrahydroindolo [4,3-fg]quinoline-9-carboxamide
CAS number: 2349358-81-0
Formula: C23H29N3O2
Molar mass: 379.5 g/mol
Purity: ≥99.3%
What is 1P-LSD?
1P-LSD (1-propionyl-lysergic acid diethylamide) is a synthetic compound. As a psychedelic drug, 1P-LSD works by binding to serotonin receptors in the brain, specifically the 5-HT2A receptor. This leads to altered states of consciousness, perception, and mood, including visual and auditory hallucinations and changes in thought patterns.
1P-LSD is primarily used as a research chemical and is not intended for human consumption. It is often used in studies of the effects of psychedelic drugs on the brain and in the development of potential therapeutic uses.
Although the safety profile of 1P-LSD has not been fully evaluated, it is known to have potentially serious psychological effects and its use can be risky. As a synthetic compound, the long-term effects of its use on human health are not well known.
How did 1P-LSD come about?
The origins of 1P-LSD date back to the mid-20th century, and it was first synthesized by Swiss chemist Albert Hofmann. It quickly gained popularity in the counterculture movements of the 1960s and 1970s, and its effects on the human mind and consciousness became the subject of intensive scientific study.
In the 1990s, a team of researchers led by David E. Nichols at Purdue University began studying the pharmacology of related compounds. Their research aimed to develop new compounds that could help elucidate the mechanisms of action and potentially lead to the development of new therapies for psychiatric disorders.
As part of this research, Nichols and his team synthesized a new compound, 1P-LSD, which is structurally similar to another compound but with an additional propionyl group on the nitrogen atom. This change was intended to increase the stability and potency of the substance and make it easier to study in the laboratory.
Today, 1P-LSD is mainly used as a research drug and is not intended for human consumption. It is often used in studies of the effects of psychedelic drugs on the brain and in the development of potential therapeutic uses.
The synthesis of 1P-LSD by Nichols and his team is an important contribution to psychedelic research. Their work in developing new compounds for study has helped to expand our understanding of the human mind and consciousness and has opened new avenues for the development of potential therapies for psychiatric disorders.
Hazard statements 1P-LSD may cause respiratory irritation
1P-LSD may cause eye irritation
1P-LSD IN CONTACT WITH EYES: Rinse eyes cautiously with water for five minutes. Remove contact lenses, if possible.
1P-LSD IN CONTACT WITH SKIN: Wash skin with soap and water.
AFTER INHALATION OF 1P-LSD: Move victim to fresh air and keep comfortable for breathing.
Disclaimer
All products sold by Pure Tech Chemicals are intended for laboratory and research purposes only. They are not for human consumption, veterinary use, or medical applications. You must be 21 years or older to purchase. Misuse of these products is strictly prohibited.
